EP3539374 - NON-HUMAN ANIMALS EXPRESSING PH-SENSITIVE IMMUNOGLOBULIN SEQUENCES [Right-click to bookmark this link] | Status | Examination is in progress Status updated on 12.02.2021 Database last updated on 03.09.2024 | |
Former | Request for examination was made Status updated on 20.03.2020 | ||
Former | The application has been published Status updated on 16.08.2019 | Most recent event Tooltip | 26.07.2024 | New entry: Reply to examination report | Applicant(s) | For all designated states Regeneron Pharmaceuticals, Inc. 777 Old Saw Mill River Road Tarrytown, NY 10591 / US | [2019/38] | Inventor(s) | 01 /
MCWHIRTER, John c/o Regeneron Pharmaceuticals, Inc. 777 Old Saw Mill River Road Tarrytown, NY 10591 / US | 02 /
MACDONALD, Lynn c/o Regeneron Pharmaceuticals, Inc. 777 Old Saw Mill River Road Tarrytown, NY 10591 / US | 03 /
MARTIN, Joel, H c/o Regeneron Pharmaceuticals, Inc. 777 Old Saw Mill River Road Tarrytown, NY 10591 / US | 04 /
MURPHY, Andrew, J c/o Regeneron Pharmaceuticals, Inc. 777 Old Saw Mill River Road Tarrytown, NY 10591 / US | [2019/38] | Representative(s) | J A Kemp LLP 80 Turnmill Street London EC1M 5QU / GB | [N/P] |
Former [2019/38] | J A Kemp 14 South Square Gray's Inn London WC1R 5JJ / GB | Application number, filing date | 19156973.0 | 15.03.2013 | [2019/38] | Priority number, date | US201261611950P | 16.03.2012 Original published format: US 201261611950 P | US201261612126P | 16.03.2012 Original published format: US 201261612126 P | US201261613352P | 20.03.2012 Original published format: US 201261613352 P | US201261736930P | 13.12.2012 Original published format: US 201261736930 P | [2019/38] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | EP3539374 | Date: | 18.09.2019 | Language: | EN | [2019/38] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 24.06.2019 | Classification | IPC: | A01K67/027, C07K16/00, C12N15/85 | [2019/38] | CPC: |
A01K67/0278 (EP,CN,IL,KR,RU,US);
A01K67/0275 (IL,RU,US);
C07K16/00 (EP,CN,IL,KR,US);
C12N15/8509 (EP,CN,IL,RU,US);
A01K2217/072 (EP,CN,IL,KR,US);
A01K2217/075 (EP,CN,IL,KR,US);
A01K2217/15 (EP,CN,IL,KR,US);
A01K2227/105 (EP,CN,IL,KR,US);
A01K2267/01 (EP,CN,IL,KR,US);
C07K2317/10 (EP,CN,IL,US);
C07K2317/21 (EP,CN,IL,KR,US);
C07K2317/565 (IL,KR);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2020/17] |
Former [2019/38] | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR | Title | German: | NICHT-MENSCHLICHE TIERE ZUR EXPRESSION PH-SENSITIVER IMMUNOGLOBULINSEQUENZEN | [2019/38] | English: | NON-HUMAN ANIMALS EXPRESSING PH-SENSITIVE IMMUNOGLOBULIN SEQUENCES | [2019/38] | French: | ANIMAUX NON HUMAINS EXPRIMANT DES SÉQUENCES D'IMMUNOGLOBULINE SENSIBLES AU PH | [2019/38] | Examination procedure | 18.03.2020 | Amendment by applicant (claims and/or description) | 18.03.2020 | Examination requested [2020/17] | 18.03.2020 | Date on which the examining division has become responsible | 12.02.2021 | Despatch of a communication from the examining division (Time limit: M04) | 14.06.2021 | Reply to a communication from the examining division | 07.11.2022 | Despatch of a communication from the examining division (Time limit: M04) | 17.03.2023 | Reply to a communication from the examining division | 27.03.2024 | Despatch of a communication from the examining division (Time limit: M04) | 25.07.2024 | Reply to a communication from the examining division | Parent application(s) Tooltip | EP13714127.1 / EP2825037 | Fees paid | Renewal fee | 13.02.2019 | Renewal fee patent year 03 | 13.02.2019 | Renewal fee patent year 04 | 13.02.2019 | Renewal fee patent year 05 | 13.02.2019 | Renewal fee patent year 06 | 13.02.2019 | Renewal fee patent year 07 | 20.03.2020 | Renewal fee patent year 08 | 23.03.2021 | Renewal fee patent year 09 | 23.03.2022 | Renewal fee patent year 10 | 21.03.2023 | Renewal fee patent year 11 | 20.03.2024 | Renewal fee patent year 12 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [A]US2006015957 (LONBERG NILS [US], et al); | [A]EP2275443 (CHUGAI PHARMACEUTICAL CO LTD [JP]); | [A]WO2011097603 (REGENERON PHARMA [US], et al); | [A]WO2011111007 (RINAT NEUROSCIENCE CORP [US], et al); | by applicant | US5599908 | US5603931 | US6586251 | US6596541 | US6774279 | US7105348 | US7294754 | US2007280945 | US2008078000 | US7576259 | US7659442 | US2010331527 | US2011111406 | US2011195454 | US2012021409 | US2012192300 | US2012192309 | US2012322108 | US2013045492 | US20100832838 |